THERAVANCE BIOPHARMA INC (TBPH:NASDAQ)
$17.07 0.03 (0.1761%)
Analysed THERAVANCE BIOPHARMA INC (TBPH:NASDAQ) News Sources
Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results
06-08-2026
yahoo.com
Theravance Biopharma, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update
10-08-2026
yahoo.com
Theravance Biopharma, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update
07-05-2026
yahoo.com
Are Options Traders Betting on a Big Move in Theravance Biopharma Stock?
13-05-2026
yahoo.com
Theravance, after clinical setbacks, agrees to $929M buyout
29-06-2026
biopharmadive.com
THERAVANCE BIOPHARMA ENTERS INTO DEFINITIVE AGREEMENT TO BE ACQUIRED BY ZYMEWORKS FOR $17.00 PER SHARE IN CASH PLUS A CONTINGENT VALUE RIGHT
29-06-2026
yahoo.com
Zymeworks to Acquire Theravance Biopharma in $929 Million Deal
29-06-2026
yahoo.com
Zymeworks To Buy Theravance Biopharma In $929M Deal – A Look At What This Deal Means For TBPH Shareholders
29-06-2026
stocktwits.com
Sector Update: Healthcare Stocks Higher Late Afternoon
29-06-2026
yahoo.com
Zymeworks agrees to buy Theravance Biopharma for $929m
30-06-2026
pharmaceutical-technology.com
What is the current price of THERAVANCE BIOPHARMA INC (TBPH:NASDAQ)?
The current price of THERAVANCE BIOPHARMA INC (TBPH:NASDAQ) is $17.07.
THERAVANCE BIOPHARMA INC (TBPH:NASDAQ) absolute price change since previous trading day?
The absolute price change of THERAVANCE BIOPHARMA INC (TBPH:NASDAQ) since the previous trading day is $0.03.
THERAVANCE BIOPHARMA INC (TBPH:NASDAQ) percentage price change since previous trading day?
The percentage price change of THERAVANCE BIOPHARMA INC (TBPH:NASDAQ) since the previous trading day is 0.1761%.
What is the most recent average sentiment score for THERAVANCE BIOPHARMA INC (TBPH:NASDAQ)?
The most recent average sentiment score for THERAVANCE BIOPHARMA INC (TBPH:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for THERAVANCE BIOPHARMA INC (TBPH:NASDAQ)?
The most recent sentiment for THERAVANCE BIOPHARMA INC (TBPH:NASDAQ) is .
SEC-8K** Filing Available For THERAVANCE BIOPHARMA INC (TBPH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.